tradmap

ONC Earnings Beone Medicines Ltd.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$2 -$1 $0 $0 2017 2017 2017 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $3B $5B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$2B -$858M $287M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $0 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $853M $2B Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$368M -$65M $237M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–31 of 31
Q2 20262026-06-300.312026-08-0510-Q
Q1 20262026-03-310.152026-05-0610-Q
FY 20252025-12-310.192026-02-2610-K
Q3 20252025-09-300.152025-11-0610-Q
Q2 20262025-06-300.072026-08-0510-Q
Q1 20262025-03-310.002026-05-0610-Q
FY 20252024-12-31-0.472026-02-2610-K
Q3 20252024-09-30-0.362025-11-0610-Q
Q2 20252024-06-30-0.272025-08-0610-Q
Q1 20252024-03-31-0.192025-05-0710-Q
FY 20252023-12-31-0.652026-02-2610-K
Q3 20242023-09-30-0.382024-11-1210-Q
Q2 20242023-06-30-0.542024-08-0710-Q
Q1 20242023-03-31-0.262024-05-0810-Q
FY 20242022-12-31-1.492025-02-2710-K
Q3 20232022-09-30-1.162023-11-0910-Q
Q2 20232022-06-30-0.752023-08-0210-Q
Q1 20232022-03-31-0.332023-05-0410-Q
FY 20232021-12-31-1.212024-02-2610-K
Q3 20222021-09-30-0.722022-11-0910-Q
Q2 20222021-06-30-0.352022-08-0810-Q
Q1 20222021-03-310.052022-05-0910-Q
FY 20222020-12-31-1.502023-02-2710-K
Q1 20212020-03-31-0.362021-05-0610-Q
FY 20212019-12-31-1.222022-02-2810-K
Q3 20182018-09-30-0.582018-11-0810-Q
FY 20182017-12-31-0.172019-02-2810-K
FY 20182017-09-300.202019-02-2810-K
FY 20182017-06-30-0.122019-02-2810-K
FY 20182017-03-31-0.102019-02-2810-K
Q3 20172016-09-30-0.212017-11-1310-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.